Next Article in Journal
Having a Child Diagnosed with Cancer: Raising the Challenges Encountered by the Caregivers at the Pediatric Oncology Ward in Egypt
Previous Article in Journal
Competitive Promoter-Associated Matrix Attachment Region Binding of the Arid3a and Cux1 Transcription Factors
Article Menu

Export Article

Open AccessFeature PaperCase Report
Diseases 2017, 5(4), 35;

Successful Treatment of Pulmonary and Cerebral Toxoplasmosis Associated with Pneumocystis Pneumonia in an HIV Patient

Department of Interregional Secure Hospital, AP-HM, University Hospital, 13915 Marseille CEDEX, France
Université Aix Marseille, CNRS 7278, IRD 198, Inserm 1095, AP-HM, URMITE, IHU Méditerranée Infection, 13915 Marseille CEDEX, France
Author to whom correspondence should be addressed.
Received: 21 November 2017 / Revised: 13 December 2017 / Accepted: 14 December 2017 / Published: 18 December 2017
(This article belongs to the Section Infectious Disease)
Full-Text   |   PDF [357 KB, uploaded 18 December 2017]   |  


In both the post and pre combination antiretroviral therapy (cART) era, Pneumocystis jirovecii and Toxoplasma gondii remain common opportunistic infectious agents. The common manifestations are pneumonia for P. jirovecii and brain abscess for T. gondii. Nevertheless, co-infection remains rare, and pulmonary toxoplasmosis is scarce, or may be underestimated because of its similarity with Pneumocystis jirovecii pneumonia. We reported an uncommon case of an AIDS patient (6 CD4 + T cells/mm3) with both pulmonary and cerebral toxoplasmosis associated with pneumocystis pneumonia. The patient presented with general weakness, fever and dyspnea. Pulmonary toxoplasmosis and pneumocystis were confirmed by microscopic examination and DNA detection in the bronchoalveolar lavage. Computed tomography imaging of the brain revealed a single characteristic cerebral toxoplasmosis lesion of the left capsular area. He was successful treated by trimethoprim/sulfamethoxaxole in conjunction with an early reintroduction of cART, and without IRIS development. During a 3-year follow-up, HIV viral load remained undetectable, and the patient did not relapse for toxoplasmosis or Pneumocystis pneumonia. View Full-Text
Keywords: Pneumocystis jirovecii; Toxoplasma gondii; pneumonia; cerebral; trimethoprim/sulfamethoxaxole Pneumocystis jirovecii; Toxoplasma gondii; pneumonia; cerebral; trimethoprim/sulfamethoxaxole

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Rey, M.-F.; Mary, C.; Sanguinetti, D.; Ranque, S.; Bartoli, C.; L’Ollivier, C. Successful Treatment of Pulmonary and Cerebral Toxoplasmosis Associated with Pneumocystis Pneumonia in an HIV Patient. Diseases 2017, 5, 35.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Diseases EISSN 2079-9721 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top